GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Yunkang Group Ltd (HKSE:02325) » Definitions » Cash Ratio

Yunkang Group (HKSE:02325) Cash Ratio : 0.85 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Yunkang Group Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Yunkang Group's Cash Ratio for the quarter that ended in Dec. 2023 was 0.85.

Yunkang Group has a Cash Ratio of 0.85. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Yunkang Group's Cash Ratio or its related term are showing as below:

HKSE:02325' s Cash Ratio Range Over the Past 10 Years
Min: 0.16   Med: 0.79   Max: 1.07
Current: 0.85

During the past 6 years, Yunkang Group's highest Cash Ratio was 1.07. The lowest was 0.16. And the median was 0.79.

HKSE:02325's Cash Ratio is ranked worse than
53.98% of 226 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.95 vs HKSE:02325: 0.85

Yunkang Group Cash Ratio Historical Data

The historical data trend for Yunkang Group's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yunkang Group Cash Ratio Chart

Yunkang Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial 0.16 0.59 0.92 0.72 0.85

Yunkang Group Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only 0.92 1.02 0.72 0.84 0.85

Competitive Comparison of Yunkang Group's Cash Ratio

For the Diagnostics & Research subindustry, Yunkang Group's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yunkang Group's Cash Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Yunkang Group's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Yunkang Group's Cash Ratio falls into.



Yunkang Group Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Yunkang Group's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=2046.163/2393.878
=0.85

Yunkang Group's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=2046.163/2393.878
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yunkang Group  (HKSE:02325) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Yunkang Group Cash Ratio Related Terms

Thank you for viewing the detailed overview of Yunkang Group's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Yunkang Group (HKSE:02325) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Lizhishan Road, Science City, Huangpu District, Guangzhou, CHN
Yunkang Group Ltd is a medical operation service provider in China. The company has three major business lines namely covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and non-medical institutions.
Executives
Huizekx Limited 2201 Interest of corporation controlled by you
Yk Development Limited 2101 Beneficial owner
Zhang Yong 2201 Interest of corporation controlled by you
Shanghai Pudong Development Bank Co., Ltd 2201 Interest of corporation controlled by you
Zhou Xinyu
Guang Zhou Da An Ji Yin Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Da An Guo Ji Ji Tuan You Xian Gong Si 2101 Beneficial owner
Guang Zhou Shi Da An Ji Yin Ke Ji You Xian Gong Si 2201 Interest of corporation controlled by you
Jin Jun Ying Limited 2201 Interest of corporation controlled by you
Mouduans Limited 2201 Interest of corporation controlled by you
Source Capital Rw Limited 2201 Interest of corporation controlled by you
Tongfuzc Limited 2201 Interest of corporation controlled by you
Wjjr Investment Limited 2201 Interest of corporation controlled by you

Yunkang Group (HKSE:02325) Headlines

No Headlines